Dimerix Ltd has released a press release.
First Approvals Received for Start of Phase 3 FSGS Trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Dimerix
- Phase 3 DMX-200 COVID-19 Study Expands into Australia
- Dimerix Closes SPP Oversubscribed
- DMX-200 CLARITY COVID-19 Study Approval in India
- Phase 3 Study in FSGS Kidney Patients Commences
- SPP and Options Prospectus
Later from Dimerix
- Pause in Trading
- DSMB Recommends Continuation of Ph3 COVID-19 Study in Europe
- Ethics Approval in Australia for Phase 3 COVID-19 Study
- Patients Dosed in DMX-200 COVID-19 Phase 3 Study in India
- First Regulatory Approval in Europe for DMX-200 FSGS Study
Follow Dimerix into a list and get an email when it puts out news.
Follow Dimerix